---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-007262"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2022-05-20T23:59:59+00:00"
generated_at: "2026-06-25T08:41:33.160381+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech holds 2022 annual meeting; all director nominees elected, say-on-pay approved

## Summary
- Annual meeting held May 18, 2022; 6,975,601 shares (50.1%) represented.
- All seven director nominees elected: Chao, Johnson, MacDonald, Nijhawan, Oakes, Pay, Sistilli.
- Advisory vote on executive compensation approved: 4,105,670 for, 373,029 against.
- Frequency vote chose 'every year' (4,213,160 votes); company will hold annual say-on-pay.
- MNP LLP appointed as independent auditor for 2023  with 6,860,304 votes in favor.

## SEC filing metadata
- accession: 0001654954-22-007262
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2022-05-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000165495422007262/0001654954-22-007262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000165495422007262/edsa_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-007262
- JSON: https://secwatch.observer/filing/0001654954-22-007262.json
- Plain text: https://secwatch.observer/filing/0001654954-22-007262.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.